Wake Forest University School of Medicine names Ebony Boulware, MD, MPH, Dean, Vice Chief Academic Officer and Chief Science Officer at Atrium Health
· Filed In: Healthcare News
L. Ebony Boulware, MD, MPH, Director of the Duke Clinical and Translational Science Institute (CTSI), Vice Dean for Translational Science in the School of Medicine, and Associate Vice Chancellor for Translational Research at Duke University, will step down from her positions at Duke on December 31, 2022, to begin a new role as Dean of the Wake Forest University School of Medicine in January 2023. Dr. Boulware will also serve as the Vice Chief Academic Officer and Chief Science Officer at Atrium Health.
Dr. Boulware, Nanaline H. Duke University Distinguished Professor in the Department of Medicine, joined the Duke faculty in 2013 as Chief of the Division of General Internal Medicine in the Department of Medicine and has served as Director of CTSI and Vice Dean for Translational Science since 2016. She has spent most of her academic career investigating how to improve health care and health outcomes for individuals and populations with chronic kidney disease, hypertension, and other chronic diseases, particularly focusing on minoritized populations.
Susanna Naggie, MD, MHS, Vice Dean for Clinical Research and Director of the Participant and Clinical Interactions Core of the current Clinical and Translational Science Award (CTSA), will immediately begin serving alongside Dr. Boulware as interim Co-Director of the CTSI. Dr. Naggie will also join the current CTSA leadership, which includes co-PIs Jennifer Li, MD, MHS, and James McNamara, MD, to manage the CTSA.
In a statement to faculty and staff, Dean Mary E. Klotman, MD, wrote, “In her roles at Duke, Dr. Boulware has been instrumental in accelerating the translation of research to clinical care, and she is a national leader in addressing the causes and effects of racial and ethnic health and health care inequities. Dr. Boulware has been a dedicated and innovative leader, and I want to thank her for her service and commitment to the School of Medicine.”
About Wake Forest University School of Medicine:
“Wake Forest University School of Medicine, one of the top medical schools in the country, prepares the next generation of health care leaders through education, research and innovation. The school of medicine is also one of the most selective medical training programs in the nation and encompasses multiple programs including MD, PA, CRNA, DNP and a variety of biomedical graduate programs.
Through excellence in education and research and direct integration into Atrium Health Wake Forest Baptist, we have cultivated a leading academic medical center, and we continue to grow.
As we look to the future, we’ve positioned our medical school to become the nexus of our evolving learning health system—an organization with a culture of learning and innovation where everyone is invited to explore questions aimed at improving how we do what we do.
And with the medical school as our health system’s nucleus, research and education become the means, not an end to accomplishing our goal of improving health.
What does that look like? As a learning health system, we’re actively and intentionally integrating research and education into patient care settings and feeding knowledge gained from those settings back into the academic ecosystem—so we can improve health not just in a distant future, but starting today.”
About L. Ebony Boulware, MD, MPH:
Dr. Boulware directs the Duke Clinical and Translational Science Institute as Vice Dean for Translational Science and Associate Vice Chancellor for Translational Research, and she is Chief of the Duke Division of General Internal Medicine in the Department of Medicine. She is a general internist, physician-scientist and clinical epidemiologist focused on improving health and health equity for individuals and communities affected by chronic health conditions such as kidney disease. A national thought leader in health equity, she has identified patient, clinician, system, and community-level barriers that result in disparate outcomes for Black and other marginalized individuals. Using pragmatic trials, she has developed successful interventions, shaped guidelines, raised physician awareness and changed clinical practice. Throughout her work, Dr. Boulware has sought to improve transparency and trustworthiness in science and medicine.
Her research has been continuously funded by the National Institutes for Health, the Patient Centered Outcomes Research Institute, and other organizations throughout her career. She has published over 200 manuscripts, book chapters, and editorials, and she mentors numerous students, residents, fellows, and faculty members. Dr. Boulware is an elected member of the American Society for Clinical Investigation, the National Academy of Medicine, and the American Academy of Arts and Sciences.